Vestal Point Capital »

Iteos Therapeutics shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Iteos Therapeutics (ITOS) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Iteos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iteos Therapeutics held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iteos Therapeutics by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $26M 1.8M 14.84

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Iteos Therapeutics

BlackRock
RA Capital Management
EcoR1 Capital
Boxer Capital
MPM Asset Management
Vanguard Group
Vestal Point Capital
MPM Oncology Impact Management
Susquehanna International
683 Capital Management
Morgan Stanley
State Street Corporation
Dimensional Fund Advisors
Citadel Advisors
Goldman Sachs Group

View all funds holding Iteos Therapeutics